Department of Pediatrics, Soroka University Medical Center, Beer Sheva, Israel.
Pediatric Pulmonary Unit, Soroka University Medical Center, Beer Sheva, Israel.
Pediatr Pulmonol. 2018 Jun;53(6):796-801. doi: 10.1002/ppul.24007. Epub 2018 Apr 14.
To further validate the use of the Modified Tal Score (MTS), a clinical tool for assessing bronchiolitis severity, by physicians with varying experience and training levels, and to determine the ability of the MTS to predict bronchiolitis severity.
This prospective cohort study included infants of <12 months of age who were diagnosed with bronchiolitis and assessed via MTS. We calculated the intra-class correlation coefficient (ICC) among four groups of raters: group 1, board-certified pediatric pulmonologists; group 2, board-certified pediatricians; group 3, senior pediatric residents; and group 4, junior pediatric residents. Clinical outcomes were determined as length of oxygen support and length of stay (LOS). We assessed MTS's prediction of these outcomes. Relative risk (RR) for clinical severity was calculated via a Generalized Linear Model.
Twenty-four physicians recorded a total of 600 scores for 50 infants (average age 5 ± 3 months; 56% male). The ICC values with group 1 as a reference were 0.92, 0.87, and 0.83, for groups 2, 3, and 4, respectively (P < 0.001). RR for oxygen support required was; 1.33 (CI 1.12-1.57), 1.26 (1.1-1.46), 1.26 (1.06-1.5), and 1.21 (0.93-1.58) for groups 1, 2, 3, and 4, respectively. RR for LOS was; 1.15 (CI 0.97-1.37), 1.19 (1.03-1.38), 1.18 (1.0-1.39), and 1.18 (0.93-1.51) for groups 1, 2, 3, and 4, respectively.
The MTS is a simple and valid scoring system for evaluating infants with acute bronchiolitis, among different physician groups. The first score upon admission is a fair predictor of oxygen requirement at 48 h, and LOS at 72 h.
进一步验证改良 Tal 评分(MTS)在不同经验和培训水平的医生中的使用,以评估毛细支气管炎的严重程度,并确定 MTS 预测毛细支气管炎严重程度的能力。
这项前瞻性队列研究纳入了<12 个月龄的毛细支气管炎患儿,通过 MTS 进行评估。我们计算了 4 组评分者的组内相关系数(ICC):第 1 组,有资质的儿科肺科医生;第 2 组,有资质的儿科医生;第 3 组,高级儿科住院医生;第 4 组,初级儿科住院医生。临床结局为氧疗时间和住院时间(LOS)。我们评估了 MTS 对这些结局的预测。使用广义线性模型计算临床严重程度的相对风险(RR)。
24 名医生共记录了 50 名婴儿的 600 个评分(平均年龄 5±3 个月;56%为男性)。以第 1 组为参考,第 2、3 和 4 组的 ICC 值分别为 0.92、0.87 和 0.83(P<0.001)。需要氧疗的 RR 分别为;1.33(CI 1.12-1.57)、1.26(1.1-1.46)、1.26(1.06-1.5)和 1.21(0.93-1.58),对应第 1、2、3 和 4 组。 LOS 的 RR 分别为;1.15(CI 0.97-1.37)、1.19(1.03-1.38)、1.18(1.0-1.39)和 1.18(0.93-1.51),对应第 1、2、3 和 4 组。
MTS 是一种简单有效的评估急性毛细支气管炎患儿严重程度的评分系统,在不同的医生群体中均有效。入院时的第一个评分可较好地预测 48 小时的氧需求和 72 小时的 LOS。